Gut microbe clues could help detect MS without needles

Credibility

Interest

Share:2 min read

Key Takeaway

A stool-based test that looks at many types of gut microbes (bacteria, fungi, and viruses) shows promise for helping detect multiple sclerosis (MS) without invasive tests.

What They Found

Researchers studied poop samples from over 1,300 people and looked not only at bacteria but also fungi and viruses in the gut. They found many microbes and metabolic functions that were different in people with MS compared to healthy people, including fewer Faecalibacterium bacteria and lower activity in a pathway that makes the amino acid methionine. Using computer programs that learn patterns (machine learning), the team built models that could tell MS patients from healthy people very well in their main data set, and fairly well in outside groups. The best models combined different types of microbe information and metabolic functions, like putting together clues from fingerprints, hair, and footprints to ID someone. This suggests gut microbe patterns could become a non-invasive sign (a biomarker) to help identify MS, but it is not yet a clinical test doctors use every day.

Who Should Care and Why

People with MS and their caregivers should care because a stool-based test could one day add a simple, non-painful tool to help with diagnosis or monitoring, similar to how a glucose meter helps track diabetes. Doctors and clinics may benefit because this kind of test could add more information without needing scans or spinal taps, though it would be used alongside—not instead of—current tests. Researchers should care because the study shows that fungi and viruses, not just bacteria, matter in MS and may open new research paths for treatments or diet-based approaches. Care teams might use this information to think about gut health (for example, diet, probiotics, or avoiding unnecessary antibiotics) as one piece of overall care, though specific changes aren’t proven yet. People interested in less invasive ways to track MS progression or risk will find this promising, like getting regular breath or stool checks instead of only seeing changes after symptoms appear.

Important Considerations

This study shows association, not proof that microbes cause MS, so we can’t assume changing the gut will fix MS. The models worked best in the original study group and were less accurate when tested on other groups, so more testing is needed across different places and populations. Before any stool-based test is used in clinics, doctors need more studies to confirm the findings, standardize testing methods, and show that using the test improves care or outcomes.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Early Research MS Genetics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like NPJ biofilms and microbiomes often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News